Novabridge Biosciences ADR
(NBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 171,405 | N/A | N/A | N/A | N/A |
| Marketable Securities | 4,597 | N/A | N/A | N/A | N/A |
| Other current assets | 19,540 | 0 | 0 | 0 | 0 |
| TOTAL | $195,542 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,319 | N/A | N/A | N/A | N/A |
| Intangibles | 44,732 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4,994 | 0 | 0 | 0 | 0 |
| TOTAL | $54,045 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $249,587 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,182 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 39,293 | 0 | 0 | 0 | 0 |
| TOTAL | $47,453 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10,872 | 0 | 0 | 0 | 0 |
| TOTAL | $11,435 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $58,888 | $N/A | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 57,664 | N/A | N/A | N/A |
| Common Shares | 11 | N/A | N/A | N/A | N/A |
| Retained earnings | -358,270 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 10,074 | 0 | 0 | 0 | 0 |
| TOTAL | $190,699 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $249,587 | $0 | $0 | $0 | $0 |